https://www.selleckchem.com/pr....oducts/mitoquinone-m
in planning target volume (PTV) coverage and OAR doses, but VMAT had less number of monitor units and shorter treatment time. Of all breast cancers, triple-negative and HER-2 positive are the most aggressive breast cancer subtypes with a high risk of recurrence and worse prognosis. The study's purpose was to further assess the molecular mechanisms underlying aggression of breast cancer. The microarray gene expression datasets of GSE29431 and GSE53752 were obtained from the GEO (Gene Expression Omnibus) database, which inclu